explore -WSS

explore

author：comprehensive 2025-09-28 02:26:57 - browse：88447

STAT Q&A — Paul Matteis (right), in 2017 with then-colleagues Seamus Fernandez (far left) Geoffrey Porges. Alex Hogan/STAT

NEW YORK — Is biotech having a renaissance in neuroscience? Can we solve the placebo effect? And what’s going to happen next year?

Paul Matteis, co-head of biotech research at Stifel, sat down with STAT at the firm’s annual health care conference here to field those questions and opine on how management teams can walk the delicate balance between hype and sandbagging. This transcript has been edited for length and clarity.

One thing I’ve been hearing lately is that biotech has entered a sort of renaissance in neuroscience. Do you agree with that?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Diagnostic tests are hitting their mathematical limits

knowledge

WSS

Fetal surgery at risk from Dobbs and new abortion restrictions

Biogen’s boardroom scandal saddles CEO with first crisis

Aspartame and sugar

Organ aging and disease risk measured by new blood test

Treatments for cramps don't cut it. Why aren't there better options?

Indictment alleges Trump's ex

leisure time

explore

focus

At least 13 dead in Texas as scorching temps continue

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Virginia high school admissions case could be legal follow

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Activists slam private health insurers over coverage restrictions

Cigna, Humana reportedly in talks to merge

Moonlake's readout produced a cash windfall. Risks remain

Judge sides with young activists in first

Anesthesiologist group: stop taking Ozempic before surgery

Maui wildfire now ranks as the fifth

focus

Mark Cuban is blaming the wrong people for high drug costs

YouTube cracks down on misinformation on cancer treatment

Hospitals are dialing back on venture capital investing

Indictment alleges Trump's ex

Be careful with at

Aspartame and sugar

hotspot

knowledge

focus

knowledge